[ Price : $8.95]
Based on safety concerns, Sarepta says it is discontinuing the development of SRP-5051 (vesleteplirsen) for treating patients with...[ Price : $8.95]
FDA grants de novo authorization to LumiTheras Valeda light delivery treatment for dry age-related macular degeneration.[ Price : $8.95]
FDA approves Caris Life Sciences MI Cancer Seek and its use as a companion diagnostic to identify cancer patients for treatment wi...[ Price : $8.95]
The American Clinical Laboratory Association submits comments to an FDA draft guidance on medical device predetermined change cont...[ Price : $8.95]
In an interview the day after the election, president-elect Donald Trumps top health advisor Robert F. Kennedy Jr. says there are ...[ Price : $8.95]
FDA grants a fourth breakthrough device designation for SeaStar Medicals Selective Cytopheretic Device.[ Price : $8.95]
FDA releases the form FDA-483 with nine observations from an inspection at the Staska Pharmaceuticals outsourcing facility in Benn...[ Price : $8.95]
Three mental health stakeholders call on two FDA advisory committees to recommend changes to the clozapine REMS.